These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33142017)

  • 1. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing.
    Godino L; Varesco L; Bruno W; Bruzzone C; Battistuzzi L; Franiuk M; Miccoli S; Bertonazzi B; Graziano C; Seri M; Turchetti D
    J Genet Couns; 2021 Jun; 30(3):665-675. PubMed ID: 33142017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parents' understanding of genome and exome sequencing for pediatric health conditions: a systematic review.
    Gereis J; Hetherington K; Ha L; Robertson EG; Ziegler DS; Barlow-Stewart K; Tucker KM; Marron JM; Wakefield CE
    Eur J Hum Genet; 2022 Nov; 30(11):1216-1225. PubMed ID: 35999452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
    Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K
    Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult patients with undiagnosed conditions and their responses to unresolved uncertainty from exome sequencing.
    Neustadt A; Owczarzak J; Mu W; Cohen JS; Erby L
    J Genet Couns; 2020 Dec; 29(6):992-1003. PubMed ID: 32030847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies.
    Robinson JO; Wynn J; Biesecker B; Biesecker LG; Bernhardt B; Brothers KB; Chung WK; Christensen KD; Green RC; McGuire AL; Hart MR; Griesemer I; Patrick DL; Rini C; Veenstra D; Cronin AM; Gray SW
    Genet Med; 2019 Dec; 21(12):2781-2790. PubMed ID: 31189963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
    Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL
    Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
    Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
    Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings.
    Bergner AL; Bollinger J; Raraigh KS; Tichnell C; Murray B; Blout CL; Telegrafi AB; James CA
    Am J Med Genet A; 2014 Nov; 164A(11):2745-52. PubMed ID: 25251809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
    Shahmirzadi L; Chao EC; Palmaer E; Parra MC; Tang S; Gonzalez KD
    Genet Med; 2014 May; 16(5):395-9. PubMed ID: 24113345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test.
    Guo F; Liu R; Pan Y; Collins C; Bean L; Ma Z; Mathur A; Da Silva C; Nallamilli B; Guruju N; Chen-Deutsch X; Yousaf R; Chin E; Balciuniene J; Hegde M
    Genet Med; 2024 Jan; 26(1):100995. PubMed ID: 37838930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
    Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
    Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling for early onset and familial dementia: Patient perspectives on exome sequencing.
    Rolf B; Blue EE; Bucks S; Dorschner MO; Jayadev S
    J Genet Couns; 2021 Jun; 30(3):793-802. PubMed ID: 33393146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
    Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
    Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability.
    Malinowski J; Miller DT; Demmer L; Gannon J; Pereira EM; Schroeder MC; Scheuner MT; Tsai AC; Hickey SE; Shen J;
    Genet Med; 2020 Jun; 22(6):986-1004. PubMed ID: 32203227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
    Phillips KA; Trosman JR; Douglas MP; Gelb BD; Ferket BS; Hindorff LA; Slavotinek AM; Berg JS; Russell HV; Devine B; Greve V; Smith HS
    Genet Med; 2022 Jan; 24(1):238-244. PubMed ID: 34906461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of unsolicited findings in clinical exome sequencing, a qualitative interview study.
    Schoot VV; Viellevoije SJ; Tammer F; Brunner HG; Arens Y; Yntema HG; Oerlemans AJM
    Eur J Hum Genet; 2021 Jun; 29(6):930-939. PubMed ID: 33637888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium.
    Amendola LM; Robinson JO; Hart R; Biswas S; Lee K; Bernhardt BA; East K; Gilmore MJ; Kauffman TL; Lewis KL; Roche M; Scollon S; Wynn J; Blout C
    J Genet Couns; 2018 Sep; 27(5):1220-1227. PubMed ID: 29497922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: Beyond the diagnosis.
    Talati AN; Gilmore KL; Hardisty EE; Lyerly AD; Rini C; Vora NL
    Prenat Diagn; 2022 May; 42(6):775-782. PubMed ID: 35132674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Counseling and Genome Sequencing in Pediatric Rare Disease.
    Elliott AM
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31501267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history.
    Codina-Solà M; Trujillano L; Abulí A; Rovira-Moreno E; Muñoz-Cabello P; Campos B; Fernández-Álvarez P; Palau D; Carrasco E; Valenzuela I; Cueto-González AM; Lasa-Aranzasti A; Limeres J; Leno-Colorado J; Costa-Roger M; Moles-Fernández A; Balmaña J; Díez O; Cuscó I; Garcia-Arumí E; Tizzano EF
    Eur J Hum Genet; 2023 Feb; 31(2):223-230. PubMed ID: 36446894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.